Patents matching “suspension”

WO 2026106858

FORMULATIONS ET PROCÉDÉS POUR MAINTENIR UNE SUSPENSION ET UNE VIABILITÉ DE CELLULES

BAYER HEALTHCARE LLC [US] · Granted May 21, 2026 · Expires May 16, 2046

US 12383516

Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent

Amphastar Pharmaceuticals, Inc. · Granted Aug 12, 2025 · Expires Aug 7, 2045

US 12350245

Stable oral suspensions of baclofen

ANI Pharmaceuticals, Inc. · Granted Jul 8, 2025 · Expires Jul 3, 2045

US 12201639

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. · Granted Jan 21, 2025 · Expires Jan 16, 2045

US 11857524

Stable oral suspensions of baclofen

ANI Pharmaceuticals, Inc. · Granted Jan 2, 2024 · Expires Dec 28, 2043

US 11471471

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

US 11382922

Aqueous oral pharmaceutical suspension compositions

ReveraGen BioPharma, Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

US 11103472

Oral suspensions comprising a non-steroidal anti-inflammatory drug (NSAID)

Infirst Healthcare Limited · Granted Aug 31, 2021 · Expires Aug 26, 2041

US 10463674

Process for manufacturing sterile ophthalmic pharmaceutical suspensions

SENTISS PHARMA PRIVATE LIMITED · Granted Nov 5, 2019 · Expires Oct 31, 2039

US 10226426

Suspension containing nano-cocrystal and manufacturing method

Takeda Pharmaceutical Company Limited · Granted Mar 12, 2019 · Expires Mar 7, 2039

US 9849100

Pharmaceutical compositions suitable for parenteral administration comprising aqueous suspensions of benzylamine derivatives having low solubilities

KalVista Pharmaceuticals Limited · Granted Dec 26, 2017 · Expires Dec 21, 2037

US 9731037

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht · Granted Aug 15, 2017 · Expires Aug 10, 2037

US 2016213609

OPHTHALMIC SUSPENSION COMPOSITION

BAUSCH & LOMB [US] · Granted Jul 28, 2016 · Expires Jul 23, 2036

US 9062288

Therapeutic methods using adipose tissue-derived cell suspensions comprising adipocytes

Regeneus LTD · Granted Jun 23, 2015 · Expires Jun 18, 2035

US 8974801

Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

Amphastar Pharmaceuticals, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

US 2015038439

METHOD FOR PREPARING SUSPENSIONS OF LOW-SOLUBILITY MATERIALS

MACLEOD STEVEN K [US] · Granted Feb 5, 2015 · Expires Jan 31, 2035

US 8779094

Low viscosity highly concentrated suspensions

The Board of Regents of the University of Texas System · Granted Jul 15, 2014 · Expires Jul 10, 2034

US 8697048

Peptide amphiphile suspension to prevent or reduce tumor formation from administered embryonic stem cells

Northwestern University · Granted Apr 15, 2014 · Expires Apr 10, 2034

US 8633034

Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution

The Regents of the University of Colorado · Granted Jan 21, 2014 · Expires Jan 16, 2034

US 8632751

Scanning suspension comprising a particle with a diameter of at least 1 micrometer

Universitair Medisch Centrum Utrecht · Granted Jan 21, 2014 · Expires Jan 16, 2034

US 8481516

Ciclesonide containing sterile aqueous suspension

TAKEDA GMBH · Granted Jul 9, 2013 · Expires Jul 4, 2033

US 8367734

Stable epinephrine suspension formulation with high inhalation delivery efficiency

Amphastar Pharmaceuticals, Inc. · Granted Feb 5, 2013 · Expires Jan 31, 2033

US 7238366

Submicron liposome suspensions obtained from preliposome lyophilizates

The Board of Regents of the University of Texas System · Granted Jul 3, 2007 · Expires Jun 28, 2027

US 7192546

Methods of forming shaped articles from suspensions

Albright & Wilson (Australia) Limited · Granted Mar 20, 2007 · Expires Mar 15, 2027